4
Changes in Ownership
Structure Therapeutics Inc. Filed Acc 0001962926-26-000009
CHIEF SCIENTIFIC OFFICER acquired 17,817 shares (option exercise)
- CHIEF SCIENTIFIC OFFICER acquired 17,817 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/form4-09032026_010924.xml…